Dr. Miao Zhu | Lymphoma | Best Researcher Award
Yangzhou University | China
Author Profile
🎓 Dr. Miao Zhu: Emerging Innovator in Gastric Cancer Research and Hematology
Dr. Miao Zhu is a dedicated Ph.D. candidate at the College of Medicine, Yangzhou University, with a profound focus on the repression of gastric tumor metastasis. Her research is centered on exploring the mechanisms behind the Celastrus Orbiculatus extracts’ effects on gastric cancer, specifically investigating splicing factor PTBP1-regulated lactation modification. Dr. Zhu’s academic journey has been marked by rigorous training and notable accomplishments in the field of medical research.
đź“š Education and Training
- Ph.D. Candidate (2021 – Present)
Yangzhou University, College of Medicine, Jiangsu, China
Dissertation: Investigating the Mechanism of Repression of Gastric Tumor Metastasis by Celastrus Orbiculatus Extracts. - M.M. in Medicine (2015 – 2018)
Xuzhou Medical School, College of Medicine, Jiangsu, China
Dissertation: Studying the Effect of Celastrus Orbiculatus Extract and Genistein on Inflammatory Thrombotic State in 38B9 Lymphoma-Bearing Mice. - B.S. in Medicine (2010 – 2015)
Nantong University, College of Medicine, Jiangsu, China
Major: Fundamentals of Medicine and Diagnostic Imaging.
🏥 Professional Experience
- Ph.D. Candidate (2021 – Present)
Key Laboratory of Syndrome Differentiation and Treatment of Gastric Cancer, Yangzhou University- Participated in multiple projects on gastric cancer, earning the First Prize of New Technology Introduction of Yangzhou.
- Developed expertise in various laboratory techniques, including cell culture, RNA extraction, PCR, and animal xenograft models.
- Resident Physician (2018 – 2021)
Department of Hematology, Subei People’s Hospital, Yangzhou, China- Specialized in diagnosing and treating internal medicine diseases and hematological tumors.
- Gained proficiency in critical medical procedures like bone marrow aspiration and deep vein catheterization.
- Researcher (2015 – 2018)
Non-coding RNA Laboratory, Yangzhou University- Conducted assays to study the intervention effects of Chinese medicine on tumors.
🏆 Honors and Awards
- 2023
- First Prize, Jiangsu Provincial Inspection Practice Innovation Competition
- First Prize, Yangzhou New Technology Introduction
- First Prize, Paper Appraisal at New Drug Innovation Forum of Jiangsu Pharmacological Society
- 2022-2023
- “Qianghuan Di” Special Scholarship, Yangzhou University
- Academic First-Class Scholarship
- Special Prize, Jiangsu Provincial Inspection Practice Innovation Competition
- 2021-2022
- Three Good Students Award, Yangzhou University Medical School
- Golden Microphone Award, Young and Middle-Aged Diagnosis and Treatment Idea Contest
- First Prize, Jiangsu Provincial Inspection Practice Innovation Competition
🚀 Conclusion
Dr. Miao Zhu’s extensive education, clinical experience, and numerous accolades demonstrate her commitment to advancing medical research, particularly in gastric cancer and hematology. Her work on the mechanisms of tumor metastasis and the therapeutic potential of traditional Chinese medicine positions her as a rising star in her field. With a solid foundation in both research and clinical practice, Dr. Zhu is poised to make significant contributions to medical science, shaping the future of cancer treatment and patient care.
📊🔬NOTABLE PUBLICATION:
- PTBP1 Drives c-Myc-Dependent Gastric Cancer Progression and Stemness
- Authors: Ni, T., Chu, Z., Tao, L., Wang, H., Liu, Y.
- Journal: British Journal of Cancer
- Year: 2023
- Betulonic Acid, as One of the Active Components of the Celastrus Orbiculatus Extract, Inhibits the Invasion and Metastasis of Gastric Cancer Cells by Mediating Cytoskeleton Rearrangement In Vitro
- Authors: Chu, Z., Luo, Y., Ni, T., Liu, Y., Wang, H.
- Journal: Molecules
- Year: 2022
- Celastrus Orbiculatus Extract Suppresses Gastric Cancer Stem Cells Through the TGF-β/Smad Signaling Pathway
- Authors: Ni, T., Chu, Z., Tao, L., Wang, H., Liu, Y.
- Journal: Journal of Natural Medicines
- Year: 2024
- PTBP1 Plays an Important Role in the Development of Gastric Cancer
- Authors: Chu, Z., Zhu, M., Luo, Y., Sunagawa, M., Liu, Y.
- Journal: Cancer Cell International
- Year: 2023
- Rescue of HLH with T and B Lymphocyte Involvement Due to Epstein-Barr Virus by PD-1 Inhibitor/Ruxolitinib and Rituximab Combination Regimens: A Case Report
- Authors: Zhu, M., Zhang, J., Shi, Q., Sun, M., Liu, Y.
- Journal: Iranian Journal of Immunology
- Year: 2023